An estimated one in five Americans live with chronic pain and current treatment options leave much to be desired.
Bristol Myers scores accelerated approval in more blood cancers for CAR-T therapy Breyanzi
Bristol Myers Squibb is bringing its CAR-T cell therapy to adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, thanks to an